tetano
Editor, Senior Moderator
J Neuroimmunol
. 2021 Apr 28;356:577590.
doi: 10.1016/j.jneuroim.2021.577590. Online ahead of print.
Guillain-Barr? syndrome associated with SARS-CoV-2 infection: A case report with long term follow up
Nowshin Papri[SUP] 1 [/SUP], Shoma Hayat[SUP] 2 [/SUP], Asif Mohammed[SUP] 2 [/SUP], Md Nure Alam Afsar[SUP] 2 [/SUP], Imran Hasan[SUP] 2 [/SUP], Ananna Rahman[SUP] 2 [/SUP], Israt Jahan[SUP] 2 [/SUP], Zhahirul Islam[SUP] 3 [/SUP]
Affiliations
Abstract
A 50-years old male presented with quadriplegia and paresthesia and was diagnosed as Guillain-Barr? syndrome (GBS). He was found positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) six weeks prior to the onset of weakness. GBS disability score was 4. Electrophysiology showed acute inflammatory demyelinating polyradiculopathy. Anti-SARS-CoV-2 IgG was found positive. Immunological tests for Campylobacter jejuni, Zika virus, Hepatitis E virus, Herpes Simplex virus, Haemophilus influanzae and Mycoplasma pneumoniae were negative. Patient received standard dose of intravenous immunoglobulin and after six months had almost complete recovery of muscle power. This case represents possible association of SARS-CoV-2 infection and GBS with good clinical outcome.
Keywords: Bangladesh; COVID-19; Guillain-Barr? syndrome; SARS-CoV-2.
. 2021 Apr 28;356:577590.
doi: 10.1016/j.jneuroim.2021.577590. Online ahead of print.
Guillain-Barr? syndrome associated with SARS-CoV-2 infection: A case report with long term follow up
Nowshin Papri[SUP] 1 [/SUP], Shoma Hayat[SUP] 2 [/SUP], Asif Mohammed[SUP] 2 [/SUP], Md Nure Alam Afsar[SUP] 2 [/SUP], Imran Hasan[SUP] 2 [/SUP], Ananna Rahman[SUP] 2 [/SUP], Israt Jahan[SUP] 2 [/SUP], Zhahirul Islam[SUP] 3 [/SUP]
Affiliations
- PMID: 33957540
- PMCID: PMC8080536
- DOI: 10.1016/j.jneuroim.2021.577590
Abstract
A 50-years old male presented with quadriplegia and paresthesia and was diagnosed as Guillain-Barr? syndrome (GBS). He was found positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) six weeks prior to the onset of weakness. GBS disability score was 4. Electrophysiology showed acute inflammatory demyelinating polyradiculopathy. Anti-SARS-CoV-2 IgG was found positive. Immunological tests for Campylobacter jejuni, Zika virus, Hepatitis E virus, Herpes Simplex virus, Haemophilus influanzae and Mycoplasma pneumoniae were negative. Patient received standard dose of intravenous immunoglobulin and after six months had almost complete recovery of muscle power. This case represents possible association of SARS-CoV-2 infection and GBS with good clinical outcome.
Keywords: Bangladesh; COVID-19; Guillain-Barr? syndrome; SARS-CoV-2.